Life-extending drug for patients with incurable breast cancer is 'too costly for NHS' - Daily Mail

Trodelvy helps patients live longer compared to chemotherapy and was approved in Scotland last month but it is too expensive to be cost-effective in England

A devastating blow has been dealt to hundreds of women with incurable breast cancer as the medicines watchdog provisionally rejected a vital drug. Trodelvy helps patients live longer compared to che… [+2319 chars]

full article...